03/31/2026
Tennessee Retina is proud to share that Dr. Reichstein and members of our Oncology team were selected to present multiple research studies at the International Society of Ocular Oncology (ISOO) Meeting in Rio de Janeiro.
ISOO is an international society of ocular oncologists and affiliated professionals, bringing together leading experts from around the world every two years. Out of nearly 350 abstracts submitted, only 75 were accepted—and we’re honored that every abstract submitted by our team was selected for presentation.
👏 Dr. Reichstein served as first author and presenter on "Preliminary Clinical Outcomes of Neoadjuvant Darovasertib in Primary Uveal Melanoma" -Tennessee Retina has the largest international patient cohort in this study.
Dr. Reichstein also contributed as co-author on several impactful studies advancing the understanding and treatment of uveal melanoma and ocular oncology care.
👏 Additional recognition to our Oncology Services Supervisor, Anderson Brock, for serving as first author on "Combined Excision plus Plaque Brachytherapy and Immunotherapy for Conjunctival Melanoma" -with contributions from Dr. Reichstein and Jamie Cohen.
Being selected across the board highlights Tennessee Retina’s continued commitment to advancing research and staying at the forefront of ocular oncology care.
🔗Read More: https://brnw.ch/21x1cWx